These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6595323)

  • 1. [Tissue polypeptide antigen in thyroid cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1289-95. PubMed ID: 6595323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J; Oehr P; Grouls V
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tissue polypeptide antigen in breast cancer].
    Nomizu T; Watanabe I; Endo S
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2287-95. PubMed ID: 6085339
    [No Abstract]   [Full Text] [Related]  

  • 4. [Humoral markers in thyroid carcinoma].
    Pinchera A; Pacini F; Martino E; Anelli S
    Minerva Med; 1986 Nov; 77(44):2089-91. PubMed ID: 3785723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human breast cancer markers].
    Remennik LV
    Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological significance of tumor marker].
    Ochi Y
    Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quality control of the RIA method for 3 tumor markers].
    Fusco A; Ciarniello P; Latella G; Milani C; Antonucci M; Scuderi A; Giannoni MF; Caprilli R
    Minerva Med; 1987 Apr; 78(7):463-4. PubMed ID: 3472102
    [No Abstract]   [Full Text] [Related]  

  • 10. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
    Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
    J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 13. [An overview of tumor markers].
    Morita R; Fukunaga M; Ohtsuka N
    Rinsho Hoshasen; 1986 Jan; 31(1):1-10. PubMed ID: 2422414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO
    Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of a new tumor marker (CA 50) in epithelial neoplasms. Preliminary study].
    Tozzoli R; Risaliti A; Masiero M; Bruno G
    Minerva Chir; 1987 Nov; 42(21):1785-8. PubMed ID: 3480454
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumor markers in the diagnosis of pancreatic carcinoma].
    Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
    Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biohumeral markers in the diagnosis of pancreatic carcinoma].
    Panucci A; Del Favero G; Falmis C; Brosolo P; Basso D; Pedrazzoli S; Baccaglini U; Marchioro L; Bonvilini P; Naccarato R
    Recenti Prog Med; 1985; 76(7-8):385-91. PubMed ID: 3865269
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of tumor markers in patients with colorectal cancer].
    Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
    Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary].
    Gadducci A; Ferdeghini M; Prato B; Bartolini T; Nicolini A; Scatena P; Facchini V; Bianchi R; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1985; 106(1):34-9. PubMed ID: 2994537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.